15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $5.6B | $208M | 19.3% | 6.0% | $217M | $1.2B | $233M |
| 2024 | $5.0B | $212M | 20.3% | 6.4% | $288M | $1.1B | $413M |
| 2023 | $4.3B | $267M | 22.8% | 7.3% | $329M | $1.1B | $344M |
| 2022 | $3.9B | $151M | 22.4% | 6.2% | $232M | $1.1B | $294M |
| 2021 | $3.4B | $140M | 22.7% | 5.5% | $183M | $1.1B | $119M |
| 2020 | $3.0B | -$8M | 22.5% | 3.7% | $101M | $1.1B | $99M |
| 2019 | $2.3B | -$76M | 22.2% | -0.0% | $11M | $1.3B | $67M |
| 2018 | $1.9B | -$6M | 21.8% | 2.0% | -$2M | $539M | $36M |
| 2017 | $1.8B | $4M | 24.4% | 1.5% | $13M | $503M | $39M |
| 2016 | $936M | -$43M | 28.0% | -1.2% | — | $468M | $10M |
| 2015 | — | -$300M | — | — | — | $423M | $16M |
| 2014 | — | -$147M | — | — | — | $423M | $740000 |
| 2013 | — | -$70M | — | — | — | $537M | $1M |
| 2012 | — | $65M | — | — | — | $226M | $62M |
| 2011 | — | $8M | — | — | — | $293M | $0 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.4B | $45M | 19.4% | 5.4% | -$21M | $1.2B | $177M |
| Dec '25 | — | $59M | — | — | $22M | $1.2B | $233M |
| Sep '25 | — | $52M | — | — | $130M | $1.2B | $310M |
| Jun '25 | — | $51M | — | — | $81M | $1.1B | $199M |
| Mar '25 | $1.3B | $47M | 19.7% | 5.9% | -$17M | $1.1B | $171M |
| Dec '24 | — | $60M | — | — | $26M | $1.1B | $413M |
| Sep '24 | — | $54M | — | — | $151M | $1.1B | $483M |
| Jun '24 | — | $53M | — | — | $186M | $1.1B | $377M |
| Mar '24 | $1.1B | $45M | 20.8% | 6.0% | -$75M | $1.1B | $220M |
| Dec '23 | — | $57M | — | — | $31M | $1.1B | $344M |
| Sep '23 | — | $56M | — | — | $53M | $1.1B | $386M |
| Jun '23 | — | $114M | — | — | $162M | $1.1B | $441M |
| Mar '23 | — | $39M | — | — | $84M | $1.1B | $298M |
| Dec '22 | — | $48M | — | — | $25M | $1.1B | $294M |
| Sep '22 | — | $39M | — | — | $80M | $1.1B | $255M |
| Jun '22 | — | $34M | — | — | $100M | $1.1B | $204M |
| Mar '22 | — | $30M | — | — | $27M | $1.1B | $146M |
| Dec '21 | — | $75M | — | — | $51M | $1.1B | $119M |
| Sep '21 | — | $35M | — | — | $46M | $1.1B | $201M |
| Jun '21 | — | $32M | — | — | $70M | $1.1B | $158M |
How the market has priced OPCH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Option Care Health, Inc.'s revenue has grown 13.3% per year. These are computed facts, not advice.
As of FY2025, Option Care Health, Inc. reported $1.2B of total debt against $233M of cash; operating income covered interest expense 6.2×.
In FY2025, gross margin was 19.3%, operating margin 6.0%, and net margin 3.7%.
As of Jun '26, Option Care Health, Inc. traded at a price-to-earnings ratio of about 16.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.